Neurobit
New York
About Neurobit
Neurobit is a leading medical technology company that develops Software as a Medical Device (SaMD) powered by AI to decipher intricate patterns in health vitals measured during sleep, termed 'sleep biomarkers'. This technology aids in delivering tailored, predictive, and precision healthcare. With a vision to establish a universally accessible health analytics system, Neurobit aims to enhance care quality and efficiency for healthcare professionals and patients. Our Biomarker Bridge initiative is at the forefront of this mission’creating a collaborative platform that connects AI-driven biomarker companies, enabling cross-disciplinary innovation, and accelerating the integration of digital biomarkers into clinical practice. Globally, over 150 esteemed universities, hospitals, and R&D centers rely on our advanced technology solutions to push the boundaries of healthcare innovation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.6M
- Funding stage: Seed
- Last round: Seed (Apr 2023)
- Website: neurobit.com
- Phone: +19292141342,+919831946222
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Fitness, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/neurobit-44843 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.